
Viva Ventures in the News
At Viva Ventures, we enjoy being part of innovative teams that are helping to change the world.
Please take a look at some of our partners and projects.





Most Recent
October, 2018
EndPoints News
In this new deal Roche is putting up $125 million for an upfront and near-term milestones in a collaboration deal embedded with $1 billion in development goal money. Another $250 million is on the line for each new therapy that manages to make it all the way to an approval.
July, 2018
Viva Biotech
August, 2018
EndPoints News
China’s Viva Biotech Holdings has applied for an IPO in Hong Kong to both fund their pursuit of promising upstarts and boost their manufacturing capabilities.
August, 2018
WhaTech
Protein expression market estimated to reach US$ 1654 million by 2022
Viva Biotech is among key players operating in the protein expression market.
July, 2018
IFR Asia
August, 2018
EndPoints News
Summing Up: Inside the Big Drug Discovery Service Industry | Healthcare 2018
Viva Biotech is a Key Player in the Drug Discovery Service Market
Our Scientific Partners*
July, 2018
Pharmaceutical Business Review
September, 2017
Nature Journal
October, 2016
Protein Science Journal
Scientist: Brian Hubbard, Ph.D.
July, 2015
Nature Journal
Crystallographic structure of a small molecule SIRT1 activator-enzyme complex
Scientist: Cheney Mao, Ph.D.
*This is only a small selection of recent publications
Portfolio Companies
Sept, 2018
Reuters
Seeking Alpha
August, 2018
Bio Space
August, 2018
Business Wire
January, 2018
Bio World
July, 2012
Globe News Wire